Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Gains from Investment Securities (2019 - 2025)

Pulmonx has reported Gains from Investment Securities over the past 7 years, most recently at -$122000.0 for Q3 2025.

  • Quarterly Gains from Investment Securities fell 206.09% to -$122000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $744000.0 through Sep 2025, up 362.9% year-over-year, with the annual reading at $556000.0 for FY2024, 1444.44% up from the prior year.
  • Gains from Investment Securities was -$122000.0 for Q3 2025 at Pulmonx, down from -$10000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $507000.0 in Q4 2024 and troughed at -$332000.0 in Q4 2023.
  • The 5-year median for Gains from Investment Securities is $5000.0 (2023), against an average of $63157.9.
  • Year-over-year, Gains from Investment Securities soared 11333.33% in 2022 and then crashed 620.0% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $290000.0 in 2021, then plummeted by 199.31% to -$288000.0 in 2022, then fell by 15.28% to -$332000.0 in 2023, then soared by 252.71% to $507000.0 in 2024, then plummeted by 124.06% to -$122000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Gains from Investment Securities are -$122000.0 (Q3 2025), -$10000.0 (Q2 2025), and $369000.0 (Q1 2025).